GS Finance Corp. Files FWP for New Securities Offering

TL;DR

**GS Finance Corp. just filed an FWP, likely signaling a new securities offering.**

AI Summary

GS Finance Corp. filed a Free Writing Prospectus (FWP) on March 24, 2026, under SEC Accession No. 0001193125-26-121601. This filing, related to File No. 333-284538-03, indicates that GS Finance Corp. is actively marketing or offering securities. For investors, this means the company is likely raising capital, which could impact future earnings or dilution, and it's crucial to review the FWP for details on the specific securities being offered.

Why It Matters

This filing signals that GS Finance Corp. is engaging in capital-raising activities, which could lead to new investments or potential dilution for existing shareholders depending on the nature of the securities.

Risk Assessment

Risk Level: medium — The risk is medium because while an FWP indicates a potential capital raise, the specific terms and impact on shareholders are not detailed in this summary filing.

Analyst Insight

An investor should seek out the full FWP document (bxca0006fwp_gsfc.htm) referenced by SEC Accession No. 0001193125-26-121601 to understand the specific terms, type, and potential impact of the securities being offered by GS Finance Corp. before making any investment decisions.

Key Players & Entities

• GS Finance Corp. (company) — the filer and subject of the FWP
• March 24, 2026 (date) — the filing date of the FWP
• 0001193125-26-121601 (null) — the SEC Accession Number for the filing
• 333-284538-03 (null) — the File Number associated with the FWP
• 200 WEST STREET NEW YORK NY 10282 (null) — the business and mailing address of GS Finance Corp.

FAQ

Key Financial Figures

• $885 — pricing date is expected to be between $885 and $915 per $1,000 face amount. See th
• $915 — date is expected to be between $885 and $915 per $1,000 face amount. See the accompa
• $1,000 — xpected to be between $885 and $915 per $1,000 face amount. See the accompanying preli
• $1,000 m — e amount of your securities)  $1,000 minus: Underwriting discount: up to 0
• $1,517.50 — st 51.75% of the face amount at least $1,517.50 July 9, 2029 at least 56.063% of th
• $1,560.63 — t 56.063% of the face amount at least $1,560.63 October 8, 2029 at least 60.375% of
• $1,603.75 — t 60.375% of the face amount at least $1,603.75 January 7, 2030 at least 64.688% of
• $1,646.88 — t 64.688% of the face amount at least $1,646.88 April 8, 2030 at least 69.00% of th
• $1,690.00 — st 69.00% of the face amount at least $1,690.00 July 8, 2030 at least 73.313% of th
• $1,733.13 — t 73.313% of the face amount at least $1,733.13 October 7, 2030 at least 77.625% of
• $1,776.25 — t 77.625% of the face amount at least $1,776.25 January 7, 2031 at least 81.938% of
• $1,819.38 — t 81.938% of the face amount at least $1,819.38 April 7, 2031 at least 86.25% of th
• $1,862.50 — st 86.25% of the face amount at least $1,862.50 July 7, 2031 at least 90.563% of th
• $1,905.63 — t 90.563% of the face amount at least $1,905.63 October 7, 2031 at least 94.875% of
• $1,948.75 — t 94.875% of the face amount at least $1,948.75 January 7, 2032 at least 99.188% of

Filing Documents

• bxca0006fwp_gsfc.htm (FWP) — 92KB
• img13093987_0.jpg (GRAPHIC) — 3KB
• img13093987_1.jpg (GRAPHIC) — 127KB
• img13093987_2.jpg (GRAPHIC) — 11KB
• 0001193125-26-121601.txt ( ) — 287KB

Risk Factors

Risk Factors An investment in the securities is subject to risks. Many of the risks are described in the accompanying preliminary pricing supplement, accompanying WFS product supplement no. 9, accompanying prospectus supplement and accompanying prospectus. Below we have provided a list of risk factors discussed in the accompanying preliminary pricing supplement (but not those discussed in the accompanying WFS product supplement no. 9, accompanying prospectus supplement and accompanying prospectus). In addition to the below, you should read in full “Selected Risk Considerations” in the accompanying preliminary pricing supplement, “Risk Factors” in the accompanying WFS product supplement no. 9, as well as the risks and considerations described in the accompanying prospectus supplement and accompanying prospectus. The following risk factors are discussed in greater detail in the accompanying preliminary pricing supplement: Risks Related to Structure, Valuation and Secondary Market Sales • Your Securities Are Subject to Automatic Redemption • Your Securities Do Not Bear Interest • The Market Value of Your Securities May Be Influenced By Many Unpredictable Factors • We Will Not Hold Shares of the Underlying Stock for Your Benefit • You Have No Shareholder Rights or Rights to Receive the Underlying Stock Risks Related to Tax • Certain Considerations for Insurance Companies and Employee Benefit Plans • The Tax Consequences of an Investment in Your Securities Are Uncertain • Foreign Account Tax Compliance Act (FATCA) Withholding May Apply to Payments on Your Securities, Including as a Result of the Failure of the Bank or Broker Through Which You Hold the Securities to Provide Information to Tax Authorities • The Estimated Value of Your Securities At the Time the Term

View Full Filing

View this FWP filing on SEC EDGAR